Ksenia Chelnokova (Pharmd

Commercial Lead Hematology/ Oncology at Swedish Orphan Biovitrum

Ksenia Chelnokova has extensive work experience in the pharmaceutical industry. Ksenia has held various roles at different companies throughout their career. From 2021 to present, they serve as the Commercial Lead Hematology/Oncology at Sobi - Swedish Orphan Biovitrum AB (publ), where they also previously worked as the Launch and Portfolio Strategy Director from 2021 to 2023. Prior to that, from 2019 to 2021, they were the Head of Business Development, International Business Sentiss AG at Sentiss Pharma Pvt. Ltd. Before joining Sentiss, Ksenia worked at Takeda for several years. Their roles at Takeda included Senior Director, Head of Market Research, Customer Insights and Forecasting, Europe and Canada from 2017 to 2019; Senior Director, Head of Global Brands Insights, Global Customer Insights from 2015 to 2016; Director, Forecasting and Analytics Lead, Global Marketing from 2013 to 2014; Director, Head of Market Insight & Analytics, Emerging Markets from 2012 to 2013; and Director, Head of International Market Research, Portfolio and Interface Management (PIM) from 2012 to 2012. Prior to Takeda, Ksenia worked at Nycomed, where they held roles such as Associate Director, International Market Research, Portfolio and Interface Management (PIM) from 2010 to 2011; Senior Market Research Manager, International Market Research from April 2010 to September 2010; Market Research Manager, International Market Research from August 2007 to March 2010; and Head of Market Intelligence Group from March 2002 to July 2007. Ksenia Chelnokova holds both a PharmD and an MBA.

Ksenia Chelnokova obtained their Doctor of Pharmacy (PharmD) degree in Pharmaceutical Sciences from the First Moscow State Medical University named after I.M. Sechenov, completing their studies from 1991 to 1996. Following this, they pursued their Bachelor's degree in Linguistics at the Moscow Humanitarian-Technical Academy (former Moscow Economic and Linguistic Institute) from 1998 to 2001. Lastly, they obtained their Master of Business Administration (MBA) degree in Marketing from the Plekhanov Russian University of Economics, completing their studies from 2004 to 2006.

Links

Previous companies

Takeda Pharmaceutical logo